Incidence of pituitary adenomas in Northern Finland in 1992-2007.
BACKGROUND
Data on the incidence of pituitary adenomas (PAs) are scant and outdated. A population-based regional cohort with thorough case identification was used to evaluate the incidence of clinically detected PAs in the era of magnetic resonance imaging.


OBJECTIVE
The objective of the study was to describe the age- and sex-specific incidence of all PA subgroups, with data on incidentally found PAs, pituitary apoplexies, and time trends.


METHODS
This was a retrospective descriptive analysis of PA patients diagnosed during 1992-2007 in Northern Finland (NFi).


METHODS
World Health Organization 2000-standardized incidence rates (SIRs) of PAs per 100,000 were measured.


CONCLUSIONS
The final cohort consisted of 355 PAs. The incidence rates of the Oulu University Hospital regional district were used as a reference to assess the applicability of our case finding over the rest of NFi. Incidence rates of all PA subgroups except microprolactinomas were statistically equal between these areas; thus, all presented SIRs are based on the NFi's cohort except Oulu University Hospital regional district-based prolactinomas and PAs overall. Overall SIR of PAs was higher (4.0 per 100,000) than in previous reports. Prolactinomas had the highest SIR: 2.2 per 100,000, followed by clinically nonfunctioning PAs (1.0) and GH-secreting (0.34), ACTH-secreting (0.17), and TSH-secreting (0.03) PAs. The gender-specific SIR was 2.2 per 100,000 in males and 5.9 per 100,000 in females. Pituitary apoplexy occurred as a presenting symptom in 11% of clinically nonfunctioning PA patients. The SIR of incidentally discovered PAs increased significantly from 1992-1999 to 2000-2007 (0.59 to 1.6, respectively; P < 0.01), which accounted for the perceived increasing trend in the overall SIR of PAs (3.8 to 4.2; P > 0.05).
Department of Otorhinolaryngology, Institute of Clinical Medicine, University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland. antti.raappana@oulu.fi
Antti
A
Raappana
John
J
Koivukangas
Tapani
T
Ebeling
Tapio
T
Pirilä
D000236:Adenoma / Q000453:epidemiology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010899:Pituitary Apoplexy / Q000453:epidemiology; D010911:Pituitary Neoplasms / Q000453:epidemiology*; D015175:Prolactinoma / Q000453:epidemiology; D012189:Retrospective Studies; D012737:Sex Factors; D013997:Time Factors; D055815:Young Adult